Literature DB >> 811315

Outbreake of Marburg virus disease in Johannesburg.

J S Gear, G A Cassel, A J Gear, B Trappler, L Clausen, A M Meyers, M C Kew, T H Bothwell, R Sher, G B Miller, J Schneider, H J Koornhof, E D Gomperts, M Isaäcson, J H Gear.   

Abstract

The first recognised outbreak of Marburg virus disease in Africa, and the first since the original epidemic in West Germany and Yugoslavia in 1967, occurred in South Africa in February 1975. The primary case was in a young Australian man , who was admitted to the Johannesburg Hospital after having toured Rhodesia. Two secondary cases occurred, one being in the first patient's travelling companion, and the other in a nurse. Features of the illness included high fever, myalgia, vomiting and diarrhoea, hepatitis, a characteristic maculopapular rash, leucopenia, thrombocytopenia, and a bleeding tendency. The first patient died on the seventh day from haemorrhage resulting from a combination of disseminated intravascular coagulation and hepatic failure. The other two patients were given vigorous supportive treatment and prophylactic heparin and recovered after an acute phase lasting about seven days. During this period on developed pancreatitis, the serum amylase remaining raised until the 32nd day after the onset of the illness. The other developed unilateral uveitis after having been asymptomatic for two months. This persisted for several weeks and Marburg virus was cultured from the anterior chamber of the eye.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 811315      PMCID: PMC1675587          DOI: 10.1136/bmj.4.5995.489

Source DB:  PubMed          Journal:  Br Med J        ISSN: 0007-1447


  10 in total

1.  A quick and accurate method for the determination of fibronogen in plasma.

Authors:  B C ELLIS; A STRANSKY
Journal:  J Lab Clin Med       Date:  1961-09

2.  Haemolytic-uraemic syndrome and heparin therapy.

Authors:  J Katz; A Lurie; B Kaplan
Journal:  Lancet       Date:  1969-09-27       Impact factor: 79.321

Review 3.  Iodine-labelled fibrinogen: a review.

Authors:  E Regoeczi
Journal:  Br J Haematol       Date:  1971-06       Impact factor: 6.998

Review 4.  Disseminated intravascular coagulation in virus diseases.

Authors:  D G McKay; W Margaretten
Journal:  Arch Intern Med       Date:  1967-08

5.  Recognition and treatment of intravascular coagulation.

Authors:  C F Abildgaard
Journal:  J Pediatr       Date:  1969-02       Impact factor: 4.406

6.  Marburg agent disease: in man.

Authors:  G A Martini
Journal:  Trans R Soc Trop Med Hyg       Date:  1969       Impact factor: 2.184

7.  Lassa fever and Marburg virus disease.

Authors:  T P Monath
Journal:  WHO Chron       Date:  1974-05

8.  The Marburg virus (vervet monkey agent).

Authors:  R Siegert
Journal:  Mod Trends Med Virol       Date:  1970

9.  Marburg virus infection in monkeys. Ultrastructural studies.

Authors:  F A Murphy; D I Simpson; S G Whitfield; I Zlotnik; G B Carter
Journal:  Lab Invest       Date:  1971-04       Impact factor: 5.662

10.  Heparin therapy in septicemia with disseminated intravascular coagulation.

Authors:  J J Corrigan; C M Jordan
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

  10 in total
  85 in total

1.  Ebola virus selectively inhibits responses to interferons, but not to interleukin-1beta, in endothelial cells.

Authors:  B H Harcourt; A Sanchez; M K Offermann
Journal:  J Virol       Date:  1999-04       Impact factor: 5.103

2.  Immunoglobulin M and G responses measured by immunofluorescence in patients with Lassa or Marburg virus infections.

Authors:  H Wulff; K M Johnson
Journal:  Bull World Health Organ       Date:  1979       Impact factor: 9.408

3.  Clinical aspects of Marburg hemorrhagic fever.

Authors:  Masfique Mehedi; Allison Groseth; Heinz Feldmann; Hideki Ebihara
Journal:  Future Virol       Date:  2011-09       Impact factor: 1.831

Review 4.  Laboratory diagnostic systems for Ebola and Marburg hemorrhagic fevers developed with recombinant proteins.

Authors:  Masayuki Saijo; Masahiro Niikura; Tetsuro Ikegami; Ichiro Kurane; Takeshi Kurata; Shigeru Morikawa
Journal:  Clin Vaccine Immunol       Date:  2006-04

5.  An overview of viral and viral-like agents in cell culture systems.

Authors:  J C Petricciani
Journal:  Cytotechnology       Date:  1998-11       Impact factor: 2.058

6.  Evidence for occurrence of filovirus antibodies in humans and imported monkeys: do subclinical filovirus infections occur worldwide?

Authors:  S Becker; H Feldmann; C Will; W Slenczka
Journal:  Med Microbiol Immunol       Date:  1992       Impact factor: 3.402

7.  Lethal experimental infections of rhesus monkeys by aerosolized Ebola virus.

Authors:  E Johnson; N Jaax; J White; P Jahrling
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

Review 8.  Ebola virus transmission.

Authors:  W L Irving
Journal:  Int J Exp Pathol       Date:  1995-08       Impact factor: 1.925

9.  Lassa fever, Marburg and Ebola virus diseases and other exotic diseases: is there a risk to Canada?

Authors:  A J Clayton
Journal:  Can Med Assoc J       Date:  1979-01-20       Impact factor: 8.262

10.  Necrotizing Scleritis, Conjunctivitis, and Other Pathologic Findings in the Left Eye and Brain of an Ebola Virus-Infected Rhesus Macaque (Macaca mulatta) With Apparent Recovery and a Delayed Time of Death.

Authors:  Derron A Alves; Anna N Honko; Mark G Kortepeter; Mei Sun; Joshua C Johnson; Luis A Lugo-Roman; Lisa E Hensley
Journal:  J Infect Dis       Date:  2015-07-07       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.